Summit Corporation PLC : Holding(s) in Company

Full Press Release Details

Accessibility: Skip TopNav

March 10, 2014 05:35 ET

Summit Therapeutics plc

For filings with the FSA include the annex
For filings with issuer exclude the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii	Summit plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights	X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: iii	Richard Griffiths and controlled undertakings
4. Full name of shareholder(s) (if different from 3.): iv	Richard Griffiths
5. Date of the transaction and date on which the threshold is crossed or reached: v	03 March 2014
6. Date on which issuer notified:	06 March 2014
7. Threshold(s) that is/are crossed or reached: vi, vii	3%

8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of shares if possible using the ISIN CODE	Situation previous to the triggering transaction	Resulting situation after the triggering transaction
Number of Shares	Number of Voting Rights	Number of shares	Number of voting rights	% of voting rights x
Direct	Direct xi	Indirect xii	Direct	Indirect
Ordinary GB00B02T3K57	Under 3%	Under 3%	25,500,000	25,500,000		3.10%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument	Expiration date xiii	Exercise/ Conversion Period xiv	Number of voting rights that may be acquired if the instrument is exercised/ converted.	% of voting rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial instrument	Exercise price	Expiration date xvii	Exercise/ Conversion period xviii	Number of voting rights instrument refers to	% of voting rights xix, xx
					Nominal	Delta
Total (A+B+C)
Number of voting rights	Percentage of voting rights
25,500,000	3.10%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
Seren Capital Management Limited	7,000,000
Cream Capital Limited	15,384,616
Richard Griffiths direct holdings	3,115,384
Total	25,500,000

The above undertakings are all controlled by Richard Griffiths

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease

12. Date on which proxy holder will cease to hold

13. Additional information:

14. Contact name:Mike Bretherton

15. Contact telephone number:01481 738724